Pia Sundqvist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pia Sundqvist has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Antal Rot
Centre for Microvascular Research The William Harvey Research Institute, Queen Mary University of London London UK
1 shared publication - Bishwa Ghimire
Institute of Biomedicine, University of Turku, Turku, Finland
1 shared publication Elin Hub
William Harvey Research Institute, Queen Mary University of London, London, UK
1 shared publicationIlkka Julkunen
Institute of Biomedicine, University of Turku, Turku, Finland
1 shared publicationIrina Piiroinen
InFLAMES Research Flagship Center, University of Turku, Turku, Finland
1 shared publication- Johanna Ivaska
Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland
1 shared publication
Latest Publications
- 15 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (110) , eadr6787
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes
Lymph node (LN) stromal cells are critical regulators of immune reactions, yet their responses to different SARS-CoV-2 vaccines remain unexplored. Here, we immunized mice with clinically approved gene- and protein-based COVID-19 vaccines targeting viral spike (S) protein and analyzed the draining LN stroma using multimodal bioimaging, single-cell transcriptomics, and functional studies. We found that messenger RNA and adenovirus vector vaccines transfected lymphatic endothelial cell and fibroblastic reticular cell subsets in vivo and led to early local S protein production in the draining LN in a vaccine-specific manner. The vaccines induced rapid transcriptomic reprogramming of the LN stromal cells, which functionally altered scavenging and parenchymal transfer of lymph-borne antigens, formation of chemokine gradients, and migration of eosinophils within LNs. Thus, distinct vaccine formulations targeting S protein differentially prime the draining LN stromal cells before the arrival of migratory dendritic cells bearing immunogens.
- 15 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (110) , eadr6787
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes
Lymph node (LN) stromal cells are critical regulators of immune reactions, yet their responses to different SARS-CoV-2 vaccines remain unexplored. Here, we immunized mice with clinically approved gene- and protein-based COVID-19 vaccines targeting viral spike (S) protein and analyzed the draining LN stroma using multimodal bioimaging, single-cell transcriptomics, and functional studies. We found that messenger RNA and adenovirus vector vaccines transfected lymphatic endothelial cell and fibroblastic reticular cell subsets in vivo and led to early local S protein production in the draining LN in a vaccine-specific manner. The vaccines induced rapid transcriptomic reprogramming of the LN stromal cells, which functionally altered scavenging and parenchymal transfer of lymph-borne antigens, formation of chemokine gradients, and migration of eosinophils within LNs. Thus, distinct vaccine formulations targeting S protein differentially prime the draining LN stromal cells before the arrival of migratory dendritic cells bearing immunogens.